Geron Corp (NAS:GERN)
$ 3.73 -0.06 (-1.58%) Market Cap: 2.21 Bil Enterprise Value: 1.86 Bil PE Ratio: 0 PB Ratio: 6.37 GF Score: 39/100

Geron Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 09:25PM GMT
Release Date Price: $2.78 (+4.91%)
Unidentified Analyst

Okay. Welcome to our 2022 Morgan Stanley Healthcare Conference. My name is [Brock], I'm an Executive Director in the Healthcare Investment Banking Group here at Morgan Stanley. Before we get started, I'll just read a quick research disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, maybe I'd like to thank you for coming to our conference today. Today, we have CEO, Chip Scarlett from Geron. Maybe Chip, would you mind telling us a little bit about yourself?

John A. Scarlett
Geron Corporation - Chairman of the Board, President & CEO

Sure. I'd be happy to. First of all, let me read a quick FLS, just like you have your disclosures, we have ours. So during the course of this fireside chat, there will be forward-looking statements regarding future events,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot